Tscan therapeutics presents phase 1 trial design for solid tumor program at the society for immunotherapy of cancer 38th annual meeting

Solid tumor program uses separate screening protocol designed to identify patients in advance of treatment protocol; on track to enroll first patient in study this year

TCRX Ratings Summary

TCRX Quant Ranking